CA3101765A1 - Extraction d'alcaloide psychoactif et composition avec dephosphorylation controlee - Google Patents

Extraction d'alcaloide psychoactif et composition avec dephosphorylation controlee Download PDF

Info

Publication number
CA3101765A1
CA3101765A1 CA3101765A CA3101765A CA3101765A1 CA 3101765 A1 CA3101765 A1 CA 3101765A1 CA 3101765 A CA3101765 A CA 3101765A CA 3101765 A CA3101765 A CA 3101765A CA 3101765 A1 CA3101765 A1 CA 3101765A1
Authority
CA
Canada
Prior art keywords
psychoactive
alkaloid
psychoactive alkaloid
dephosphorylated
phosphorylated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3101765A
Other languages
English (en)
Inventor
Ryan Moss
Benjamin Lightburn
Lisa Ranken
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Psilo Scientific Ltd
Original Assignee
Psilo Scientific Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Psilo Scientific Ltd filed Critical Psilo Scientific Ltd
Priority to CA3101765A priority Critical patent/CA3101765A1/fr
Priority to BR112022025780A priority patent/BR112022025780A2/pt
Priority to IL299453A priority patent/IL299453A/en
Priority to CA3173030A priority patent/CA3173030C/fr
Priority to IL299449A priority patent/IL299449A/en
Priority to IL298561A priority patent/IL298561A/en
Priority to MX2022016533A priority patent/MX2022016533A/es
Priority to IL299450A priority patent/IL299450A/en
Priority to IL299452A priority patent/IL299452A/en
Priority to CA3137016A priority patent/CA3137016C/fr
Priority to IL297791A priority patent/IL297791A/en
Priority to AU2021290454A priority patent/AU2021290454B2/en
Priority to CA3169140A priority patent/CA3169140A1/fr
Priority to PCT/CA2021/050813 priority patent/WO2021253116A1/fr
Priority to IL299448A priority patent/IL299448A/en
Priority to IL305632A priority patent/IL305632A/en
Priority to EP21825817.6A priority patent/EP4161546A1/fr
Priority to IL299451A priority patent/IL299451A/en
Priority to US17/348,697 priority patent/US11331357B2/en
Priority to US17/483,601 priority patent/US11298388B2/en
Priority to US17/587,731 priority patent/US11510952B2/en
Priority to US17/697,798 priority patent/US11571450B2/en
Priority to US17/702,701 priority patent/US11642385B2/en
Publication of CA3101765A1 publication Critical patent/CA3101765A1/fr
Priority to AU2022291411A priority patent/AU2022291411B2/en
Priority to AU2022291416A priority patent/AU2022291416B2/en
Priority to AU2022291414A priority patent/AU2022291414B2/en
Priority to AU2022291413A priority patent/AU2022291413B2/en
Priority to AU2022291410A priority patent/AU2022291410B2/en
Priority to AU2023285751A priority patent/AU2023285751A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
CA3101765A 2019-06-17 2020-12-04 Extraction d'alcaloide psychoactif et composition avec dephosphorylation controlee Pending CA3101765A1 (fr)

Priority Applications (29)

Application Number Priority Date Filing Date Title
CA3101765A CA3101765A1 (fr) 2020-12-04 2020-12-04 Extraction d'alcaloide psychoactif et composition avec dephosphorylation controlee
IL305632A IL305632A (en) 2020-06-17 2021-06-14 Extraction of psychoactive compounds from psychedelic mushrooms
EP21825817.6A EP4161546A1 (fr) 2020-06-17 2021-06-14 Compositions comprenant des composés psychoactifs à partir d'organismes psychoactifs
IL299453A IL299453A (en) 2020-06-17 2021-06-14 Extraction and composition of psychoactive alkaloids with inhibited dephosphorylation
IL299449A IL299449A (en) 2020-06-17 2021-06-14 Standard psychoactive alkaloid extract composition
IL298561A IL298561A (en) 2020-06-17 2021-06-14 Methanol-based extraction of psychoactive compounds from a mushroom
MX2022016533A MX2022016533A (es) 2020-06-17 2021-06-14 Composiciones que comprenden compuestos psicoactivos de organismos psicoactivos.
IL299450A IL299450A (en) 2020-06-17 2021-06-14 Dephosphorylation-controlled extraction of phosphorylatable psychoactive alkaloids
IL299452A IL299452A (en) 2020-06-17 2021-06-14 Extraction and composition of psychoactive alkaloids with controlled dephosphorylation
CA3137016A CA3137016C (fr) 2019-06-17 2021-06-14 Extraction d'alcaloide psychoactif et composition avec dephosphorylationattenuees
IL297791A IL297791A (en) 2020-06-17 2021-06-14 Compounds composed of psychoactive compounds from psychoactive organisms
AU2021290454A AU2021290454B2 (en) 2020-06-17 2021-06-14 Process for Obtaining a Purified Psychoactive Alkaloid Solution
CA3169140A CA3169140A1 (fr) 2019-06-17 2021-06-14 Extraction d'alcaloides psychoactifs capables de phosphorylation a dephosphorylation controlee
PCT/CA2021/050813 WO2021253116A1 (fr) 2020-06-17 2021-06-14 Compositions comprenant des composés psychoactifs à partir d'organismes psychoactifs
IL299448A IL299448A (en) 2020-06-17 2021-06-14 A process for obtaining a purified psychoactive alkaloid solution
BR112022025780A BR112022025780A2 (pt) 2020-06-17 2021-06-14 Método para gerar um extrato de alcaloide psicoativo, método para gerar um extrato de alcaloide psicoativo fosforilado e método para gerar um extrato de alcaloide psicoativo desfosforilado
CA3173030A CA3173030C (fr) 2020-06-17 2021-06-14 Extraction d'alcaloide psychoactif principalement phosphoryle au moyen d'alcali
IL299451A IL299451A (en) 2020-06-17 2021-06-14 Extraction of a psychoactive alkaloid is mainly by means of alkali
US17/348,697 US11331357B2 (en) 2020-06-17 2021-06-15 Methods and compositions comprising psychoactive compounds from psychoactive organisms
US17/483,601 US11298388B2 (en) 2020-06-17 2021-09-23 Psychoactive alkaloid extraction and composition with controlled dephosphorylation
US17/587,731 US11510952B2 (en) 2020-06-17 2022-01-28 Ethanol extraction of psychoactive compounds from psilocybin fungus
US17/697,798 US11571450B2 (en) 2020-06-17 2022-03-17 Aqueous extraction of psychoactive compounds from psilocybin fungus
US17/702,701 US11642385B2 (en) 2020-06-17 2022-03-23 Basic extraction of psychoactive compounds from psychoactive organisms
AU2022291411A AU2022291411B2 (en) 2020-06-17 2022-12-19 Psychoactive alkaloid extraction and composition with inhibited dephosphorylation
AU2022291410A AU2022291410B2 (en) 2020-06-17 2022-12-19 Standardized psychoactive alkaloid extract composition
AU2022291413A AU2022291413B2 (en) 2020-06-17 2022-12-19 Predominantly phosphorylated psychoactive alkaloid extraction using alkali
AU2022291414A AU2022291414B2 (en) 2020-06-17 2022-12-19 Psychoactive alkaloid extraction and composition with controlled dephosphorylation
AU2022291416A AU2022291416B2 (en) 2020-06-17 2022-12-19 Dephosphorylation-controlled extraction of phosphorylatable psychoactive alkaloids
AU2023285751A AU2023285751A1 (en) 2020-06-17 2023-12-19 Powdered Composition Containing a Mushroom Extract Comprising a Psychoactive Alkaloid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA3101765A CA3101765A1 (fr) 2020-12-04 2020-12-04 Extraction d'alcaloide psychoactif et composition avec dephosphorylation controlee

Publications (1)

Publication Number Publication Date
CA3101765A1 true CA3101765A1 (fr) 2022-06-04

Family

ID=81828112

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3101765A Pending CA3101765A1 (fr) 2019-06-17 2020-12-04 Extraction d'alcaloide psychoactif et composition avec dephosphorylation controlee

Country Status (1)

Country Link
CA (1) CA3101765A1 (fr)

Similar Documents

Publication Publication Date Title
US11331357B2 (en) Methods and compositions comprising psychoactive compounds from psychoactive organisms
CA3157550C (fr) Composition d'alcaloide psychoactif injectable et preparation connexe
US11382942B2 (en) Extraction of psychoactive compounds from psilocybin fungus
CA3173030C (fr) Extraction d'alcaloide psychoactif principalement phosphoryle au moyen d'alcali
CA3101765A1 (fr) Extraction d'alcaloide psychoactif et composition avec dephosphorylation controlee
CA3134640C (fr) Extraction d'alcaloides psychoactifs purifies au moyen d'acetone acide
AU2022361507B2 (en) Liquid-liquid extraction of purified psychoactive alkaloid
CA3103707C (fr) Composition normalisee d'extrait d'alcaloide psychoactif
AU2022321046B2 (en) Pre-evaporation standardization of extracted psychoactive compounds
US20220152136A1 (en) Methods and compositions comprising psychoactive compounds from psychoactive organisms
CA3137016C (fr) Extraction d'alcaloide psychoactif et composition avec dephosphorylationattenuees
CA3161491C (fr) Composition d'alcaloide psychoactif a vaporiser et preparation connexe
CA3169140A1 (fr) Extraction d'alcaloides psychoactifs capables de phosphorylation a dephosphorylation controlee